Japan Vietnam Medical Investment and Development Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Japan Vietnam Medical Investment and Development's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare Industry Growth | 13.4% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 31 Mar 2017 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Japan Vietnam Medical Investment and Development makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 17 | 499,432 | -31,694 | 120,726 | 0 |
31 Mar 16 | 507,338 | -1,335,782 | 1,195,390 | 0 |
30 Sep 15 | 604,401 | 86,906 | 46,869 | 0 |
30 Jun 15 | 791,985 | 157,414 | 42,593 | 0 |
31 Mar 15 | 893,174 | 175,644 | 43,619 | 0 |
31 Dec 14 | 923,077 | 177,789 | 43,765 | 0 |
30 Sep 14 | 864,100 | 125,048 | 40,455 | 0 |
30 Jun 14 | 668,528 | 61,269 | 42,108 | 0 |
31 Mar 14 | 636,574 | 45,688 | 38,266 | 0 |
31 Dec 13 | 594,056 | 41,680 | 38,396 | 0 |
30 Sep 13 | 774,365 | 127,795 | 37,816 | 0 |
30 Jun 13 | 898,171 | 178,393 | 35,547 | 0 |
Quality Earnings: Insufficient data to determine if JVC has high quality earnings.
Growing Profit Margin: Insufficient data to determine if JVC's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if JVC's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare JVC's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if JVC's earnings growth over the past year exceeded the Healthcare industry average.
Return on Equity
High ROE: JVC has a negative Return on Equity (0%), as it is currently unprofitable.